e-learning
resources
London 2016
Monday, 05.09.2016
Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
HFNC: A new therapeutic approach in patients with chronic heart failure and Cheyne-Stokes breathing
Maria Antonietta Mazza (Avellino, Italy), Maria Antonietta Mazza, Gianfranco Scotto di Frega, Anna Annunziata, Rosa Cauteruccio, Pasquale Imitazione, Antonella Marotta, Maria Cardone, Giuseppe Fiorentino
Source:
International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Session:
Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Session type:
Thematic Poster
Number:
2391
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maria Antonietta Mazza (Avellino, Italy), Maria Antonietta Mazza, Gianfranco Scotto di Frega, Anna Annunziata, Rosa Cauteruccio, Pasquale Imitazione, Antonella Marotta, Maria Cardone, Giuseppe Fiorentino. HFNC: A new therapeutic approach in patients with chronic heart failure and Cheyne-Stokes breathing. Eur Respir J 2016; 48: Suppl. 60, 2391
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Related content which might interest you:
Sleep quality and duration in patients with chronic heart failure and sleep disordered breathing
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Day-night pattern of defibrillator shocks in patients with chronic heart failure: The impact of Cheyne-Stokes respiration and obstructive sleep apnoea
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Implications of revised rules on scoring apneic and hypopneic respiratory events in heart failure patients with nocturnal Cheyne-Stokes respiration
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013
Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016
Evaluation of the apnea-hypopnea index determined by adaptive-servo ventilation devices in heart failure patients with sleep disordered breathing
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Prediction of therapeutic effectiveness of nocturnal oxygen supplementation in Cheyne-Stokes breathing
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Hemodynamic effects of Cheyne-Stokes respiration in heart failure?
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Prevalence and course of sleep-disordered breathing in acute decompensated heart failure
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014
Validation of a Cheyne-Stokes respiration (CSR) detection algorithm for a CPAP device
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014
Contactless monitoring for sleep disordered-breathing, respiratory and cardiac co-morbidity in an elderly independent living cohort
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
Prevalence of sleep-disordered breathing related symptoms and results from an objective vigilance test in patients with chronic heart failure
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013
Clinical validation of a novel FOT-based APAP device for treatment of obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
Quality of life and exercise capacity in lung transplant recipients with and without sleep-disordered breathing
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014
The efficacy of oral appliance in patients with severe obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Short term effects of neck-based treatment and monitoring device for positional obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Atrial dysrhythmia control through cardioversion improves sleep disordered breathing in patients with heart failure
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Predictors of increased daytime sleepiness in patients with COPD
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
A novel postal-based approach to diagnosing obstructive sleep apnoea in a high risk population
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014
Performance assessment of a novel medical device for home monitoring of CPAP treatment in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013
Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept